ELCC 2016 | ASSESS trial: Blood test for EGFR mutation in advanced non-small cell lung cancer

At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, Martin Reck, MD, PhD, from LungenClinic Grosshansdorf, Grosshansdorf, Germany, discusses ASSESS, a trial of the utility of circulating-free tumor DNA in the plasma for the detection of epidermal growth factor receptor (EGFR) mutation status in patients with advanced non-small cell lung cancer.

Warning: count(): Parameter must be an array or an object that implements Countable in /home/vjoncology/public_html/wp-content/themes/vj/single.php on line 104
Share this video  

Warning: Invalid argument supplied for foreach() in /home/vjoncology/public_html/wp-content/themes/vj/single.php on line 296

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter